Thermo Fisher to Distribute Synthego Synthetic Guide RNA Products for CRISPR – Genetic Engineering & Biotechnology News
HuronReport |
Thermo Fisher to Distribute Synthego Synthetic Guide RNA Products for CRISPR
Genetic Engineering & Biotechnology News “With the addition of TrueGuide synthetic gRNAs, Invitrogen’s TrueEdit portfolio now provides end-to-end solutions for researchers’ genome editing applications,” added Helge Bastian, VP and General Manager of Synthetic Biology for Thermo Fisher Scientific. Thermo Fisher Scientific to Market, Sell Synthego Synthetic Guide RNAsGenomeWeb Synthego and Thermo Fisher Scientific Align to Manufacture and Distribute Synthetic Guide RNA Products for CRISPR …Marketwired (press release) |
HuronReport |
Thermo Fisher to Distribute Synthego Synthetic Guide RNA Products for CRISPR
Genetic Engineering & Biotechnology News “With the addition of TrueGuide synthetic gRNAs, Invitrogen’s TrueEdit portfolio now provides end-to-end solutions for researchers’ genome editing applications,” added Helge Bastian, VP and General Manager of Synthetic Biology for Thermo Fisher Scientific. Thermo Fisher Scientific to Market, Sell Synthego Synthetic Guide RNAsGenomeWeb Synthego and Thermo Fisher Scientific Align to Manufacture and Distribute Synthetic Guide RNA Products for CRISPR …Marketwired (press release) |
FierceBiotech |
Startup Palleon has a sweet plan for cancer immunotherapy
FierceBiotech Startup Palleon has a sweet plan for cancer immunotherapy. by Phil Taylor |. Oct 4, 2017 9:25am. Glycan-sensing checkpoints enable both innate and adaptive immune responses to cancer, says Jim Broderick, M.D., Palleon’s CEO and founder. |
FierceBiotech |
Startup Palleon has a sweet plan for cancer immunotherapy
FierceBiotech Startup Palleon has a sweet plan for cancer immunotherapy. by Phil Taylor |. Oct 4, 2017 9:25am. Glycan-sensing checkpoints enable both innate and adaptive immune responses to cancer, says Jim Broderick, M.D., Palleon’s CEO and founder. |
FierceBiotech |
Startup Palleon has a sweet plan for cancer immunotherapy
FierceBiotech Startup Palleon has a sweet plan for cancer immunotherapy. by Phil Taylor |. Oct 4, 2017 9:25am. Glycan-sensing checkpoints enable both innate and adaptive immune responses to cancer, says Jim Broderick, M.D., Palleon’s CEO and founder. |
|
CRISPR-Gold Repairs DMD Gene in Mice and Improves Strength and Agility
Genetic Engineering & Biotechnology News Scientists in the U.S. have developed a non-viral approach to delivering the CRISPR-Cas9 gene editing system to cells, which when tested in the mdx mouse model of Duchenne muscular dystrophy (DMD) repaired the faulty DMD gene, leading to improved … |
The Global Health News (press release) (blog) |
Cancer Immunotherapy Market : Improved Immunity and Slow Growth of Cancer Cells to Drive Demand
The Global Health News (press release) (blog) MarketResearchReports.biz has recently added a new market study to its repository, titled “Cancer Immunotherapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.” According to the report, this market is driven by … |